Annotation Detail for FAT2

Basic Information
Top
Pathway ID | Pathway Name |
---|
P00012 | Cadherin signaling pathway |
P00057 | Wnt signaling pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FAT2 mRNA | affects expression | 16483693
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of FAT2 mRNA | decreases expression | 17616710
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of FAT2 mRNA | increases expression | 16221955
|
D011374 |
Progesterone |
Progesterone results in decreased expression of FAT2 mRNA | decreases expression | 18037150
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of FAT2 mRNA | decreases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.95 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.74 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.41 | 16175315 15562024 17614352 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.24 | 15894690 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.10 | 16285004 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.98 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.36 | 15131321 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
3.95 | 17259670 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.22 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
4.11 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.84 | 15623463 15878914 16704527 15547733 15150132 16510608 15547721 16805852 15264214 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
4.58 | 3609246 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.14 | 12083418 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.89 | 15869954 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
5.96 | 12083418 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.96 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.49 | 14714311 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.77 | 8812269 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
3.02 | 18709148 14757943 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.46 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
3.07 | 11408345 17203775 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.44 | 9802331 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.61 | 17393432 16525653 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
4.93 | 17132714 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.95 | 18045962 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.82 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.33 | 17575124 12958204 |